Yunyu Mao

Clinical Center of Biotherapy at Zhongshan Hospital

BIOGRAPHY

Yunyu Mao has not added Biography.

If you are Yunyu Mao and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Current status and future development of anti-HIV chimeric antigen receptor T-cell therapy.

Immunotherapy Feb, 2021 | Pubmed ID: 33225803

Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing.

Biomarker research Oct, 2020 | Pubmed ID: 33292642

PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo.

Biomarker research Nov, 2020 | Pubmed ID: 33292688

Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study.

Cell discovery May, 2024 | Pubmed ID: 38740803

INSTITUTIONS

Fudan University

JOVE ARTICLES

Ying Xue^*,1,

Yunyu Mao^*,2,

Qibin Liao³,

Chen Zhao⁴,

Xiaoyan Zhang^1,2,4,

Jianqing Xu^1,2,4

¹Institutes of Biomedical Sciences, Fudan University,

²Clinical Center of Biotherapy at Zhongshan Hospital, Fudan University,

³Department of Oncology and Bio-therapeutic Center, Shenzhen Third People's Hospital, Southern University of Science and Technology,

⁴Shanghai Public Health Clinical Center, Fudan University

Cancer Research

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

Education

Authors

Librarians

ABOUT JoVE